Actuate Therapeutics shares owned by Long Corridor Asset Management
Quarter-by-quarter ownership of Actuate Therapeutics shares owned by Long Corridor Asset Management
from 13F filings
Historical chart of Long Corridor Asset Management investment in Actuate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Actuate Therapeutics held by Long Corridor Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Actuate Therapeutics by Long Corridor Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $931k | 125k | 7.45 |
More positions owned by Long Corridor Asset Management
View all positions for Long Corridor Asset Management